A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation

Diagnostic tests that detect antibodies (AB) against SARS-CoV-2 for evaluation of seroprevalence and guidance of health care measures are important tools for managing the COVID-19 pandemic. Current tests have certain limitations with regard to turnaround time, costs and availability, particularly in...

Descripción completa

Detalles Bibliográficos
Autores principales: Redecke, Vanessa, Tawaratsumida, Kazuki, Larragoite, Erin T., Williams, Elizabeth S. C. P., Planelles, Vicente, Spivak, Adam M., Hirayama, Lincoln, Elgort, Marc, Swenson, Shane, Smith, Rick, Worthen, Bryan, Zimmerman, Russ, Slev, Patricia, Cahoon, Ben, Astill, Mark, Häcker, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718524/
https://www.ncbi.nlm.nih.gov/pubmed/34969960
http://dx.doi.org/10.1038/s41598-021-04298-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718524/
https://www.ncbi.nlm.nih.gov/pubmed/34969960
http://dx.doi.org/10.1038/s41598-021-04298-1

Ejemplares similares